Literature DB >> 2970054

Dental management of the patient with hemophilia.

J O Katz1, G T Terezhalmy.   

Abstract

Classic hemophilia is the most common inherited bleeding diathesis. Recent advances in the management of hemophilia have enabled many hemophiliac patients to receive outpatient dental care on a routine basis. An overview of hemophilia, including etiology, clinical features, and recent advances in treatment, is presented. Guidelines for dental management of the hemophiliac patient are discussed.

Entities:  

Mesh:

Year:  1988        PMID: 2970054     DOI: 10.1016/0030-4220(88)90081-3

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol        ISSN: 0030-4220


  5 in total

1.  Christmas disease: diagnosis and management of a haemorrhagic diathesis following dentofacial trauma.

Authors:  Sridevi B Tamagond; Santosh I Hugar; Anil Patil; SandhyaRani Huddar
Journal:  BMJ Case Rep       Date:  2015-01-07

2.  No increased bleeding risk for oral surgery in patients with severe congenital bleeding disorders due to intense perioperative management.

Authors:  G Goldmann; C Berens; N Marquardt; R Reich; J Oldenburg; M Wenghoefer
Journal:  Oral Maxillofac Surg       Date:  2014-12-10

3.  Knowledge of Oral Hygiene among Hemophilic Patients Referred to Iranian Hemophilia Society.

Authors:  Mohammad Abrisham; Mehdi Tabrizizadeh; Alireza Ghateh
Journal:  J Dent Res Dent Clin Dent Prospects       Date:  2009-06-05

Review 4.  Dental implant treatment for renal failure patients on dialysis: a clinical guideline.

Authors:  Quan Yuan; Qiu-Chan Xiong; Megha Gupta; Rosa María López-Pintor; Xiao-Lei Chen; Dutmanee Seriwatanachai; Michael Densmore; Yi Man; Ping Gong
Journal:  Int J Oral Sci       Date:  2017-06-23       Impact factor: 6.344

5.  The evaluation of fibrin sealants and tissue adhesives in oral surgery among patients with bleeding disorders.

Authors:  Gülsüm Ak; Esra Alpkılıç Başkırt; Esma Kürklü; Meltem Koray; Hakkı Tanyeri; Bülent Zülfikar
Journal:  Turk J Haematol       Date:  2012-03-05       Impact factor: 1.831

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.